Phenolic compounds, antioxidant activity and in vitro inhibitory potential against key enzymes relevant for hyperglycemia and hypertension of commonly used medicinal plants, herbs and spices in Latin America.
Traditionally used medicinal plants, herbs and spices in Latin America were investigated to determine their phenolic profiles, antioxidant activity and in vitro inhibitory potential against key enzymes relevant for hyperglycemia and hypertension. High phenolic and antioxidant activity-containing medicinal plants and spices such as Chancapiedra (Phyllantus niruri L.), Zarzaparrilla (Smilax officinalis), Yerba Mate (Ilex paraguayensis St-Hil), and Huacatay (Tagetes minuta) had the highest anti-hyperglycemia relevant in vitro alpha-glucosidase inhibitory activities with no effect on alpha-amylase. Molle (Schinus molle), Maca (Lepidium meyenii Walp), Caigua (Cyclanthera pedata) and ginger (Zingiber officinale) inhibited significantly the hypertension relevant angiotensin I-converting enzyme (ACE). All evaluated pepper (Capsicum) genus exhibited both anti-hyperglycemia and anti-hypertension potential. Major phenolic compounds in Matico (Piper angustifolium R.), Guascas (Galinsoga parviflora) and Huacatay were chlorogenic acid and hydroxycinnamic acid derivatives. Therefore, specific medicinal plants, herbs and spices from Latin America have potential for hyperglycemia and hypertension prevention associated with Type 2 diabetes.
Ranilla
Lena Galvez
LG
Escuela de Alimentos, Facultad de Recursos Naturales, Pontificia Universidad Católica de Valparaíso, Avenida Waddington 716, Playa Ancha, Valparaíso, Chile.
Kwon
Young-In
YI
Apostolidis
Emmanouil
E
Shetty
Kalidas
K
D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use*; D001628:Beverages / Q000032:analysis*; D001713:Biphenyl Compounds / Q000378:metabolism; D002212:Capsicum / Q000737:chemistry; D002851:Chromatography, High Pressure Liquid; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D065089:Glycoside Hydrolase Inhibitors; D006943:Hyperglycemia / Q000188:drug therapy* / Q000201:enzymology; D006973:Hypertension / Q000188:drug therapy* / Q000201:enzymology; D007843:Latin America; D007703:Peptidyl-Dipeptidase A / Q000378:metabolism; D010636:Phenols / Q000627:therapeutic use*; D008517:Phytotherapy; D010851:Picrates / Q000378:metabolism; D010946:Plants, Medicinal / Q000737:chemistry*; D017365:Spices / Q000032:analysis; D034421:Sus scrofa; D000516:alpha-Amylases / Q000037:antagonists & inhibitors
D000975:Antioxidants; D001713:Biphenyl Compounds; D004791:Enzyme Inhibitors; D065089:Glycoside Hydrolase Inhibitors; D010636:Phenols; D010851:Picrates; C004931:1,1-diphenyl-2-picrylhydrazyl; D000516:alpha-Amylases; D007703:Peptidyl-Dipeptidase A